GemVax&KAEL Co.Ltd (082270) - Total Liabilities
Based on the latest financial reports, GemVax&KAEL Co.Ltd (082270) has total liabilities worth ₩101.65 Billion KRW (≈ $68.88 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 082270 shareholders equity momentum to track the company's year-over-year net asset growth rate.
GemVax&KAEL Co.Ltd - Total Liabilities Trend (2010–2025)
This chart illustrates how GemVax&KAEL Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See 082270 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
GemVax&KAEL Co.Ltd Competitors by Total Liabilities
The table below lists competitors of GemVax&KAEL Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fourlis Holdings S.A.
AT:FOYRK
|
Greece | €693.83 Million |
|
Taj GVK Hotels & Resorts Limited
NSE:TAJGVK
|
India | Rs3.60 Billion |
|
Galan Lithium Limited
F:9CH
|
Germany | €14.42 Million |
|
Young Optics Inc
TW:3504
|
Taiwan | NT$1.44 Billion |
|
Grupa Azoty Zaklady Chemiczne Police SA
WAR:PCE
|
Poland | zł2.77 Billion |
|
Octodec
JSE:OCT
|
South Africa | ZAC4.94 Billion |
|
BlackRock New York Municipal Income Trust
NYSE:BNY
|
USA | $183.12 Million |
|
Seohee Construction Co. Ltd
KQ:035890
|
Korea | ₩568.13 Billion |
Liability Composition Analysis (2010–2025)
This chart breaks down GemVax&KAEL Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see GemVax&KAEL Co.Ltd (082270) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.78 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.64 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how GemVax&KAEL Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for GemVax&KAEL Co.Ltd (2010–2025)
The table below shows the annual total liabilities of GemVax&KAEL Co.Ltd from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩101.65 Billion ≈ $68.88 Million |
-16.51% |
| 2024-12-31 | ₩121.74 Billion ≈ $82.50 Million |
+348.65% |
| 2023-12-31 | ₩27.13 Billion ≈ $18.39 Million |
+61.60% |
| 2022-12-31 | ₩16.79 Billion ≈ $11.38 Million |
-8.50% |
| 2021-12-31 | ₩18.35 Billion ≈ $12.44 Million |
-22.22% |
| 2020-12-31 | ₩23.59 Billion ≈ $15.99 Million |
-65.42% |
| 2019-12-31 | ₩68.23 Billion ≈ $46.24 Million |
+16.07% |
| 2018-12-31 | ₩58.78 Billion ≈ $39.84 Million |
-37.27% |
| 2017-12-31 | ₩93.71 Billion ≈ $63.51 Million |
-31.22% |
| 2016-12-31 | ₩136.25 Billion ≈ $92.34 Million |
+2.81% |
| 2015-12-31 | ₩132.53 Billion ≈ $89.81 Million |
+112.55% |
| 2014-12-31 | ₩62.35 Billion ≈ $42.26 Million |
-20.50% |
| 2013-12-31 | ₩78.43 Billion ≈ $53.15 Million |
+9.38% |
| 2012-12-31 | ₩71.70 Billion ≈ $48.59 Million |
+24.38% |
| 2011-12-31 | ₩57.65 Billion ≈ $39.07 Million |
+226.40% |
| 2010-12-31 | ₩17.66 Billion ≈ $11.97 Million |
-- |
About GemVax&KAEL Co.Ltd
GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution p… Read more